SLC39A10 and neoplasm: This result was possibly due to competition with other ncRNAs, such as NORAD and MCM3AP-AS1 lncRNAs that silence these miRNAs by increasing the expression of TRIP13 and the SLC39A10/PTEN/Akt axis, accelerating tumor progression [37,38].